Arteaga CL - Search Results

1

Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery.

Bellinger AM, Arteaga CL, Force T, Humphreys BD, Demetri GD, Druker BJ, Moslehi JJ. Bellinger AM, et al. Among authors: arteaga cl. Circulation. 2015 Dec 8;132(23):2248-58. doi: 10.1161/CIRCULATIONAHA.115.010484. Circulation. 2015. PMID: 26644247 Free PMC article. Review.

2

New strategies in HER2-overexpressing breast cancer: many combinations of targeted drugs available.

Abramson V, Arteaga CL. Abramson V, et al. Among authors: arteaga cl. Clin Cancer Res. 2011 Mar 1;17(5):952-8. doi: 10.1158/1078-0432.CCR-09-1947. Epub 2011 Jan 19. Clin Cancer Res. 2011. PMID: 21248299 Free PMC article. Review.

3

Impact of genomics on personalized cancer medicine.

Arteaga CL, Baselga J. Arteaga CL, et al. Clin Cancer Res. 2012 Feb 1;18(3):612-8. doi: 10.1158/1078-0432.CCR-11-2019. Clin Cancer Res. 2012. PMID: 22298893

4

Intrinsic and acquired resistance to HER2-targeted therapies in HER2 gene-amplified breast cancer: mechanisms and clinical implications.

Rexer BN, Arteaga CL. Rexer BN, et al. Among authors: arteaga cl. Crit Rev Oncog. 2012;17(1):1-16. doi: 10.1615/critrevoncog.v17.i1.20. Crit Rev Oncog. 2012. PMID: 22471661 Free PMC article. Review.

5

Heart failure and breast cancer therapies: moving towards personalized risk assessment.

Francis SA, Cheng S, Arteaga CL, Moslehi J. Francis SA, et al. Among authors: arteaga cl. J Am Heart Assoc. 2014 Feb 28;3(1):e000780. doi: 10.1161/JAHA.113.000780. J Am Heart Assoc. 2014. PMID: 24584746 Free PMC article. No abstract available.

6

The PI3K/AKT Pathway as a Target for Cancer Treatment.

Mayer IA, Arteaga CL. Mayer IA, et al. Among authors: arteaga cl. Annu Rev Med. 2016;67:11-28. doi: 10.1146/annurev-med-062913-051343. Epub 2015 Oct 14. Annu Rev Med. 2016. PMID: 26473415 Review.

7

Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia.

Arteaga CL. Arteaga CL. Semin Oncol. 2002 Oct;29(5 Suppl 14):3-9. doi: 10.1053/sonc.2002.35642. Semin Oncol. 2002. PMID: 12422308 Review.

8

ErbB-targeted therapeutic approaches in human cancer.

Arteaga CL. Arteaga CL. Exp Cell Res. 2003 Mar 10;284(1):122-30. doi: 10.1016/s0014-4827(02)00104-0. Exp Cell Res. 2003. PMID: 12648471 Review.

9

Targeting HER1/EGFR: a molecular approach to cancer therapy.

Arteaga C. Arteaga C. Semin Oncol. 2003 Jun;30(3 Suppl 7):3-14. Semin Oncol. 2003. PMID: 12840796 Review.

10

Challenges in the development of anti-epidermal growth factor receptor therapies in breast cancer.

Arteaga CL, Truica CI. Arteaga CL, et al. Semin Oncol. 2004 Feb;31(1 Suppl 3):3-8. doi: 10.1053/j.seminoncol.2004.01.006. Semin Oncol. 2004. PMID: 15052538 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

425 results

Search Page

Filters